HealthDay: Immunotherapy drug did not increase adverse surgery events
A University of Cincinnati study found administering an immunotherapy drug before surgery for oral cavity cancer did not lead to increased rates of complications during and after surgery.
HealthDay featured the research, recently published in JAMA Otolaryngology - Head & Neck Surgery, that evaluated outcomes during and after surgery when patients with head and neck cancer were given the immunotherapy drug pembrolizumab prior to surgery.
"What we found was that patients who received preoperative treatment with immunotherapy did not have an increase in morbidities around the time of surgery,” said Alice Tang, MD, first author on the study, assistant professor of clinical otolaryngology in UC’s College of Medicine, a UC Health physician and a University of Cincinnati Cancer Center member.
Featured photo at top of Alice Tang, MD, center, with patient. Photo provided by UC Health.
Related Stories
CCM welcomes Sekyung Jang as Assistant Professor of Music Therapy
June 12, 2026
UC College-Conservatory of Music Dean Pete Jutras has announced the appointment of Sekyung Jang, PhD, as CCM's new Assistant Professor of Music Therapy. Her faculty appointment officially begins on Aug. 15, 2026, and Jang will work with college leadership to develop a new program in Music Therapy at CCM in partnership with UC's College of Medicine and the Osher Center for Integrative Health. Jang is an educator, scholar and music therapist passionate about fostering a culture of learning in which students feel safe to explore new ideas, make mistakes, and freely and respectfully receive and give feedback. Jang’s teaching is characterized by a balanced combination of lectures, experiential learning opportunities, and discussion-based instruction that helps students integrate theory and practice.
Taking a second look at surgery eligibility for patients with lung cancer who smoke
June 11, 2026
Researchers at the University of Cincinnati College of Medicine have found that patients who continue to smoke ahead of lung cancer surgery have a higher risk of pulmonary complications, but their short-term mortality rate is similar to patients who were able to stop smoking before surgery.. Their findings were published recently in the Journal of. American College of Surgeons
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.